3659 results for «326»
3659 results
Outcomes after novel transcatheter and surgical tricuspid valve interventions
21 Nov 2021 – From PCR London Valves 2021
Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...
Emergent transcatheter therapy
21 Nov 2021 – From PCR London Valves 2021
This series of 3 videos presented during the PCR London Valves 2021 Congress allows you to appreciate an emergent mitral ViV implantation after a recent re-do bioprosthetic AVR, a cardiogenic shock after transfemoral mitral valve reconstruction, and MitraClip for torrential mitral regurgitation with Impella CP support.
Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion
21 Nov 2021 – From PCR London Valves 2021
Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!
Unusual situations in valvular interventions
21 Nov 2021 – From PCR London Valves 2021
Let's discover an electrosurgical removal of an entrapped central venous catheter, witness a coronary extra-adventitial hematoma complication of transcatheter tricuspid annuloplasty, and appreciate buddy balloon technique as bailout strategy during RVOT stent embolization, among others, in this special PCR London Valves 2021 session dedicated to unusual...
Transcatheter mitral, aortic and pulmonary valve implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 to learn about acute heart failure hospitalizations following TAVI in the U.S., share a peripheral hospital's experiences with structural valve service modernization, enjoy percutaneous transseptal mitral valve implantation in Brazil, and more!
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.
EAPCI: patient initiatives around the world
22 Nov 2021 – From PCR London Valves 2021
In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE Aapproval , its Fourth FDA IDE DEB approval
10 Jan 2023
Over 1,000 patients enrolled in landmark SELUTION DeNovo study
14 Mar 2023
MedAlliance leads US Sirolimus DEB race: first US patient enrolled into SELUTION SLR coronary sirolimus DEB study
25 Jan 2023
MedAlliance announces enrollment of over 1,660 patients in landmark SELUTION DeNovo study
14 Sep 2023
MedAlliance acquired by Cordis for up to USD 1.135 billion
02 Oct 2023
MedAlliance to be acquired by Cordis
18 Oct 2022
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
24 Oct 2022
Why hypertension is a major unresolved problem
02 Oct 2024
Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.
Author
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention
06 Mar 2023
Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...
Author
Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure
03 Feb 2022
Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial
03 Sep 2025
Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.
Author
